Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (2243)	10/9/1997 9:43:00 AM
From: Oliver & Co	of 6136

I have been treating only HIV patients for the past 6 years. My own experience is that most ID specialist are not really prepared to deal with these patients on an OP basis, they are not PCPs, and are really not interested, and their offices are not equiped to handle these type of patients. (Most of them), furthermore ID specialists really spend over 80% of their time in the hospital. My own partner, an ID for more than 10 years, had to be trained in primary care for the HIV. Since the big conference in Toronto last year, there is a move for forming a specialty, called Special Immunology, some university hospital are setting up fellowships. And there is a move to form a Board of Special Immunology. Bottom line, if the doctor does not dedicate most of his/her time to this field, he will fall behind. The guidelines are geared to those who do not specialize. Watch for a board to be set up by 1999 the latest. Stay immune.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next